Neopharmed Gentili
ItalyEntry
2023
Hold
3yr
Status
Active
Who owns Neopharmed Gentili?
Neopharmed Gentili is currently owned by Renaissance Partners through NB Renaissance Fund III (2019 vintage), since 2023. Across its history, Neopharmed Gentili has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Renaissance PartnersNB Renaissance Fund III · 2019 · Mid-Large Buyout
3 ownership periods · full history below
Key facts
HQItaly
SectorHealthcare
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2018 · present
Renaissance PartnersActive
2023 · present(3yr) · NB Renaissance Fund III · 2019 · Mid-Large Buyout
Narval InvestimentiActive
2023 · present(3yr) · Narval Investimenti (Evergreen Holding) · 2004 · Buyout
More from NB Renaissance Fund III
Other portfolio companies in the same fund.
More PE-backed in Pharma
Comparable pharma deals from other GPs.
Laboratoires Delbert
Active
Socadif
France
France
AMW
Active
SHS Gesellschaft für Beteiligungsmanagement
Germany· 2026
Germany· 2026Basic Pharma
Active
SHS Gesellschaft für Beteiligungsmanagement
Netherlands· 2026
Netherlands· 2026
Cinclus Pharma
Active
Claret Capital Partners
Sweden· 2026
Sweden· 2026InfoRLife
Active
BC Partners
Switzerland· 2026
Switzerland· 2026
IRAB
Active
ARCHIMED
Spain· 2026
Spain· 2026Track Neopharmed Gentili
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Neopharmed Gentili.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue